Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Reversible cerebral vasoconstriction syndrome associated with interferon beta-1a use for multiple sclerosis.
[Reduction of spastic increased muscle tone in multiple sclerosis by the nonopioid analgesic flupirtine].
A map of the human neocortex showing the estimated overall myelin content of the individual architectonic areas based on the studies of Adolf Hopf.
Copaxone
Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein.
Severe delayed heart failure in three multiple sclerosis patients previously treated with mitoxantrone.
Fumarate treatment in progressive forms of multiple sclerosis: first results of a single-center observational study.
Myelin Gordon Research Conference
Mylan's ANDA for Three Times Per Week Generic Copaxone® 40 mg/mL Accepted for Filing by FDA
Multiple sclerosis: Mitoxantrone promotes differential effects on immunocompetent cells in vitro.
Dimethyl fumarate (BG-12, Tecfidera) - NICE says yes in draft final guidance
Headwaters of the zebrafish -- emergence of a new model vertebrate.
Interleukin-10 but not transforming growth factor-β1 gene expression is up-regulated by vitamin D treatment in multiple sclerosis patients.
Guillain-Barré Syndrome (42 Cases) Occurring During a Zika Virus Outbreak in French Polynesia.
Our Products (page shows "Copaxone" as a trade name for glatiramer acetate)
UCSF Seminar: "Neuron-glia interactions regulate CNS node of Ranvier assembly."
Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 clinical trial.
Two cases of relapses in primary progressive multiple sclerosis after fingolimod withdrawal.
Radiologically isolated syndrome: 5-year risk for an initial clinical event.
The low EOMES/TBX21 molecular phenotype in multiple sclerosis reflects CD56+ cell dysregulation and is affected by immunomodulatory therapies.
Ethnicity and prevalence of multiple sclerosis in east London.
Effect of disease duration on personality type in multiple sclerosis patients and healthy individual.
Getting a Handle on Lymphopenia With Tecfidera
Epigenetic Modulation of Human Induced Pluripotent Stem Cell Differentiation to Oligodendrocytes.
Chronic Inflammatory Demyelinating Polyneuropathy Following Anti-TNF-α Therapy With Infliximab for Crohn's Disease.
Pages
« first
‹ previous
…
86
87
88
89
90
91
92
93
94
…
next ›
last »